Author Index: P
Author Index: P
The Effect of Formulary Benefit Design on Utilization of Prescription Opioids by Disabled Medicare Part D Beneficiaries, Impacts of Medical Marijuana Policies on Initiation of Marijuana Use: Evidence from National Longitudinal Surveys of Youth 1997, Does Opioid Use Deterrence Increase Heroin Deaths? Evidence from the Reformulation of OxyContin, The Impact of State Medical Marijuana Laws on Infant Health
Returns to Specialization: Evidence from the Outpatient Surgery Market, Does Medicare Managed Care Affect Diabetic Patient Cost, Use and Quality Associated with Different Medical Labor Inputs?, Estimating the Impact of Eliminating the Employer Sponsored Health Insurance Tax Exemption on Macroeconomic Growth, What is the Impact of Returning to Pre-ACA Private Health Insurance Designs?, Premium and Cross-Premium Elasticity of Medicare Health Plan Choices
The effect of e-cigarette minimum legal purchase ages on cigarette use among pregnant teenagers, Health Insurance Expansions and Safety Net Provider Behavior: Evidence from Substance Use Disorder Providers, The Impact of Terrorism on Stress and Substance Use: Evidence from the Boston Marathon Bombing, Effects of Marketplace Premiums on Uninsurance
Association between Wealth, Education and Obesity in Women: Evidence from 111 Demographic and Health Surveys in 55 Low- and Middle-Income Countries, Association between wealth, education and obesity in women: evidence from 111 Demographic and Health Surveys in 55 low- and middle-income countriesAssessing the relationship between national poverty rates and health outcomes, Breaking Bad: Are Meth Labs Justified in Dry Counties?
Choice Inconsistencies in Health Insurance Exchanges, Evaluating the Allocative Efficiency in Long Term Care Using Variation in Occupancies, Trade-offs of simplifying complex choices: early evidence from the ACA Exchanges, Private provision of social insurance: drug-specific price elasticities and pricing in Medicare Part D, Reducing Inappropriate Prescribing of Controlled Substances in Medicare Part D: Evidence from a Randomized Intervention